Practical Considerations for Chargeable Expanded Access: Bridging Global Access Gaps While Driving Biopharma Sustainability
- Evaluate global access disparities, and how chargeable expanded access can advance global reach and patient access
- Navigate country-specific models and feasibility to tailor programs to local rules and economics
- Gain insights into practical application of chargeable expanded access in key markets including implementation challenges, protection of product valuation, and practical lessons learned